Clinical Trial Update: TachoSil Paediatric Liver Trial (TC-019-IN) [Phase 3]

View source ↗

Summary

Phase 3 pediatric liver trial of TachoSil (TC-019-IN) sponsored by Nycomed has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• TachoSil (fibrin sealant patch)

Snippet

Sponsor: Nycomed | Conditions: Liver Diseases | Phase 3 | Status: COMPLETED